Barley Grass for Cholesterol Management

Research suggests that barley grass and its derived components may support cholesterol management, with a majority of available studies reporting reductions in total cholesterol, LDL-cholesterol, and related lipid markers. The evidence base includes animal studies, in vitro work, two narrative reviews, and one randomized controlled trial in type 2 diabetic patients, with proposed mechanisms involving antioxidant activity, LDL oxidation inhibition, dietary fiber effects, and bioactive compounds such as polysaccharides. Studies indicate that findings are largely consistent in preclinical models, though human evidence remains limited, and one clinical trial of barley sprout extract found no significant reduction in total or LDL-cholesterol compared to placebo, introducing an important note of caution. Overall, while the body of research is directionally supportive, the predominance of animal and observational data means conclusions about human benefit should be drawn cautiously pending more robust clinical trials.